Inhibitor Therapeutics, Inc.
INTI· OTC
INTIInhibitor Therapeutics, Inc.
Filed May 12, 2014 · 10-Q · 42 days after period end · 0001193125-14-194777
| Metric | Q1 2014 | Q1 2013 |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$196.49K | -$60.55K |
| EPS Diluted | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inhibitor Therapeutics, Inc. · CIK 1042418 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 12, 2014 · 42 d after period end
